Chutian Yuanchuang Biotechnology (Changsha) Co., Ltd.

Chutian Yuanchuang Biotechnology (Changsha) Co., Ltd. (abbreviated as Chutian Yuanchuang) is a holding subsidiary of Chutian Technology Co., Ltd. It is a joint venture established by Chutian Technology and Kezhong Yuanchuang, serving as a supplier of integrated separation and purification solutions and services for global biopharmaceutical enterprises. It also engages in the research, development, and manufacturing of core components such as pumps and valves, and is located in the Chutian Industrial Park in Ningxiang, Hunan. The core team of Chutian Yuanchuang comes from the China Aerospace Science and Industry Corporation. It has also introduced top international talents from MILLIPORE and GE, and conducts technical and product cooperation with Japan's JNC Corporation. Since 2012, it has been engaged in the research, development, and manufacturing of downstream chromatography, ultrafiltration, and other equipment, and was among the earliest in China to produce large-molecule separation and purification equipment. To date, our product line covers a full set of purification, ultrafiltration, inline dilution, and other equipment required for downstream purification at laboratory, pilot, and production scales, and we can provide corresponding process development guidance. At present, the company has established good cooperative relationships with hundreds of enterprises at home and abroad. Its products have been exported to Japan, India, Brazil, Russia, Cambodia, and many other countries. With stable performance, safety, reliability, and ease of use, they have won widespread praise from customers. The company follows Chutian Technology's core values of "being a respected person, making respected products, and building a respected enterprise" and its business philosophy of "customer-centric, dedicated to strivers, and oriented by target responsibility and results." It upholds Kezhong Yuanchuang's concepts of "creation, responsibility, and sharing," adheres to independent innovation, promotes the development of domestically produced biopharmaceutical equipment, and helps customers reduce resin loss, improve resin utilization, increase production efficiency, lower production costs, ensure data integrity and traceability, and guarantee product quality in R&D and production processes, thereby creating value for customers.